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Abstract
Background  and  objectives: Nonsteroidal  anti-inﬂammatory  drugs  (NSAIDs)  are  frequently  used
to control  arthroscopic  pain.  Addition  of  oral  effective  opioid  ‘‘codeine’’  to  NSAIDs  may  be  more
effective and  decrease  parenteral  opioid  consumption  in  the  postoperative  period.  The  aim  of
this study  was  to  compare  the  efﬁcacy  and  side  effects  of  naproxen  sodium  and  a  new  prepa-
ration naproxen  sodium-codeine  phosphate  when  administered  preemptively  for  arthroscopic
meniscectomy.
Methods:  Sixty-one  patients  were  randomized  into  two  groups  to  receive  either  oral  naproxen
sodium (Group  N)  or  naproxen  sodium-codeine  phosphate  (Group  NC)  before  surgery.  The  surgery
was carried  out  under  general  anesthesia.  Intravenous  meperidine  was  initiated  by  patient-
controlled  analgesia  (PCA)  for  all  patients.  The  primary  outcome  measure  was  pain  score  at
the ﬁrst  postoperative  hour  assessed  by  the  Visual  Analogue  Scale  (VAS).  Sedation  assessed  by
Ramsey Sedation  Scale,  ﬁrst  demand  time  of  PCA,  postoperative  meperidine  consumption,  side
effects and  hemodynamic  data  were  also  recorded.
Results:  The  groups  were  demographically  comparable.  Median  VAS  scores  both  at  rest  and
on movement  were  signiﬁcantly  lower  in  Group  NC  compared  with  Group  N,  except  18th hour
on movement  (p  <  0.05).  The  median  time  to  the  ﬁrst  demand  of  PCA  was  shorter  in  Group  N
compared with  Group  NC  (p  <  0.001).  Meperidine  consumption  was  higher  in  Group  N  compared
with Group  NC  (p  <  0.001).  There  was  no  difference  between  groups  with  respect  to  side  effects
(p >  0.05).
Conclusions:  The  combination  of  naproxen  sodium-codeine  phosphate  provided  more  effective
analgesia  than  naproxen  sodium  and  did  not  increase  side  effects.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2014  Sociedade  Brasileir
reserved. This study was carried out in Baskent University, Faculty of Medicine, Department of Anesthesiology and Reanimation, Adana, Turkey.
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Comparac¸ão  dos  efeitos  analgésicos  pós-operatórios  de  naproxeno  sódico
e  naproxeno  sódico-fosfato  de  codeína  em  artroscopia  de  menisco
Resumo
Justiﬁcativa  e  objetivos:  Os  anti-inﬂamatórios  não  esteróides  (AINEs)  são  frequentemente  usa-
dos para  controlar  a  dor  após  artroscopia.  A  adic¸ão  de  um  opiáceo  oral  eﬁcaz  (codeína)  aos  AINEs
pode ser  mais  efetiva  e  diminuir  o  consumo  de  opiáceo  parenteral  no  pós-operatório.  O  objetivo
deste estudo  foi  comparar  a  eﬁcácia  e  os  efeitos  colaterais  de  naproxeno  sódico  e  uma  nova
preparac¸ão, naproxeno  sódico-fosfato  de  codeína,  quando  administrados  preventivamente  para
meniscectomia  artroscópica.
Métodos:  Sessenta  e  um  pacientes  foram  randomicamente  divididos  em  dois  grupos  para  rece-
ber naproxeno  sódico  por  via  oral  (Grupo  N)  ou  naproxeno  sódico-fosfato  de  codeína  (Grupo
NC) antes  da  cirurgia.  A  cirurgia  foi  realizada  sob  anestesia  geral.  Meperidina  intravenosa  foi
iniciada por  meio  de  analgesia  controlada  pelo  paciente  (ACP)  para  todos  os  pacientes.  O  des-
fecho primário  foi  o  escore  de  dor  na  primeira  hora  de  pós-operatório,  avaliada  com  a  Escala
Visual Analógica  (EVA).  A  sedac¸ão  foi  avaliada  usando  a  Escala  de  Sedac¸ão  de  Ramsey.  A  primeira
demanda de  ACP,  o  consumo  de  meperidina  no  pós-operatório,  os  efeitos  colaterais  e  os  dados
hemodinâmicos  também  foram  registrados.
Resultados:  Os  grupos  foram  demograﬁcamente  comparáveis.  As  medianas  dos  escores  EVA
tanto em  repouso  quanto  em  movimento  foram  signiﬁcativamente  menores  no  Grupo  NC  com-
parado ao  Grupo  N;  exceto  para  movimento  na  avaliac¸ão  de18  horas  (p  <  0,05).  A  mediana  do
tempo até  a  primeira  demanda  de  ACP  foi  menor  no  Grupo  N  em  comparac¸ão  com  o  Grupo  NC
(p <  0,001).  O  consumo  de  meperidina  foi  maior  no  Grupo  N  em  comparac¸ão  com  o  Grupo  NC
(p <  0,001).  Não  houve  diferenc¸a  entre  os  grupos  em  relac¸ão  aos  efeitos  colaterais  (p  >  0,05).
Conclusões:  A  combinac¸ão  de  naproxeno  sódico-fosfato  de  codeína  forneceu  analgesia  mais
efetiva que  naproxeno  sódico,  sem  aumentar  os  efeitos  colaterais.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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nurse  unaware  of  the  study  60  min  before  surgery.  Patients  inntroduction
rthroscopic  knee  surgery  is  a  common  surgical  inter-
ention.  There  is  evidence  that  effective  postoperative
ain  management  facilitates  discharge  and  more  rapid
unctional  improvement  of  these  patients.1,2 Nonsteroidal
nti-inﬂammatory  drugs  (NSAIDs)  are  frequently  used  for
ontrolling  arthroscopic  pain1,2 and  have  been  administered
lone  or  as  intraarticular  combinations  with  local  anes-
hetics  or  opioids  for  these  procedures.2,3 This  group  of
rugs  have  been  demonstrated  to  reduce  pain  and  inﬂam-
ation  due  to  arthroscopy,  as  well  as  effusions  related  to
nﬂammation,  by  inhibiting  prostaglandin  synthesis.4 The
reoperative  administration  of  NSAIDs  may  be  more  effec-
ive  in  reducing  postoperative  pain  by  inhibiting  prostanoid
roduction  before  the  development  of  tissue  injury.1
Although  the  efﬁcacy  of  oral  naproxen  sodium  as  a  pre-
mptive  medication  has  been  shown  for  arthroscopic  knee
urgery,5 the  preemptive  efﬁcacy  of  oral  naproxen  sodium-
odeine  phosphate  has  not  yet  been  investigated  to  our
nowledge.  Codeine  is  a  prodrug  with  well-known  analgesic
fﬁcacy,  and  it  is  frequently  used  in  pain  management.  It  is
etabolized  to  its  active  form,  morphine,  by  the  liver.6
This  study  aims  to  compare  the  efﬁcacy  of  single
reemptive  dose  of  oral  naproxen  sodium  versus  a  new
ombination  of  oral  naproxen  sodium-codeine  phosphate  on
ostoperative  pain  in  adult  patients  undergoing  arthroscopic
eniscectomy.
G
Faterials and methods
he  Baskent  University  Institutional  Review  Board  and  Ethics
ommittee  approved  this  prospective,  randomized,  double-
lind  study  (Project  number:  KA12/268).  The  study  was
upported  by  Baskent  University  Research  Fund  and  was
ompleted  within  6  months.  Patients  undergoing  arthro-
copic  meniscectomy  were  included  in  the  study.  The
xclusion  criteria  were  as  follows:  ≤18  years  of  age,  hyper-
ensitivity  to  NSAIDs  and/or  codeine,  history  of  a  peptic
lcer,  gastritis,  upper  gastrointestinal  bleeding,  a  coagula-
ion  disorder,  hepatic  failure,  renal  impairment,  pregnancy,
nd  the  use  of  NSAID,  opioid  and  other  analgesic  agents  up
o  the  time  of  the  surgery.
During  the  preoperative  examination,  patients  were
nformed  about  the  study  parameters,  including  pain  man-
gement  methods  to  be  used  during  the  study,  drugs  involved
nd  potential  side  effects.  Written  informed  consent  was
btained  from  all  patients.
The  randomization  scheme  automatically  created  by  a
omputer  was  kept  in  closed  envelopes.  These  envelopes
ere  prepared  by  an  anesthesiologist  who  was  not  part
f  the  study.  Before  surgery,  patients  were  assigned  to
ither  Group  N  or  Group  NC  according  to  the  randomiza-
ion  scheme.  Drugs  were  given  orally  to  both  groups  by  aroup  N  (n  =  30)  received  naproxen  sodium  550  mg  (Apranax
ort®, Abdi  Ibrahim  Ilac,  Istanbul/Turkey)  and  patients  in
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Enrollment Assessed for eligibility (n=62)
Lost to follow-up (n=0)
Discontinued Naproxen sodium (n=0)
Lost to follow-up (n=0)
Discontinued Naproxen sodium
 codeine phosphate (n=0)
Randomized (n=61)
Allocation
Follow-up
Analysis
Analysed (n=30)
♦Excluded from analysis (n=0)
Analysed (n=31)
 ♦Excluded from analysis (n=0)
Excluded (n=1)
♦Not meeting inclusion criteria (n=1)
♦Declined to participate (n=0)
♦Other reasons (n=0)
Allocated to group NC (n=31)
♦Received Naproxen sodium-codeine
phosphate (n=31)
♦Did not receive Naproxen sodium-codeine
 phosphate (n=0)
Allocated to group N (n=30)
♦Received Naproxen sodium (n=30)
♦Did not receive Naproxen sodium (n=0)
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fFigure  1  Study  ﬂow  chart.  Group  N,  naproxen  sodium  g
Group  NC  (n  =  31)  received  naproxen  sodium-codeine  phos-
phate  550  mg  +  30  mg  tablets  (Apranax  Plus®,  Abdi  Ibrahim
Ilac,  Istanbul/Turkey)  (Fig.  1).
Following  transfer  to  the  operating  room,  patients  were
monitored  by  pulse-oximetry,  electrocardiography  and  non-
invasive  blood  pressure.  Induction  and  maintenance  of
anesthesia  were  performed  by  an  anesthesiologist  blinded
to  the  study.  Intravenous  propofol  (2  mg/kg)  and  fentanyl
(0.5  g/kg)  were  used  for  induction  and  intravenous  rocuro-
nium  was  used  as  a  muscle  relaxant  (0.6  mg/kg).  Following
endotracheal  intubation,  anesthesia  was  maintained  with
isoﬂurane  (1--1.5%)  and  a  mixture  of  nitrous  oxide  and  oxy-
gen  (50%  +  50%).  At  the  end  of  the  operation,  neuromuscular
blockade  was  reversed  with  neostigmine  (0.05  mg/kg)  and
atropine  (0.015  mg/kg).  Patients  were  then  extubated  and
transferred  to  the  recovery  room.
In  the  recovery  room,  intravenous  meperidine  was  ini-
tiated  by  patient-controlled  analgesia  (PCA;  10  mg  bolus,
20  min  lockout,  no  basal  infusion  and  4  h  limit)  for  all
patients.
Data  were  recorded  by  an  anesthesia  technician  blinded
to  the  study  drugs.  Postoperative  pain  levels  at  rest  and
on  movement  were  evaluated  using  the  Visual  Analogue
Scale  (VAS;  0  =  no  pain  and  10  =  the  worst  pain  possible)  and
recorded  at  15  and  30  min  and  at  1,  2,  4,  6,  12  and  18  h
postoperatively.
Sedation  scores  were  assessed  using  the  Ramsey  Seda-
tion  Scale  (1:  anxious  and  agitated;  2:  cooperative,  oriented
and  calm;  3:  drowsy,  responsive  to  orders;  4:  asleep,  but
U
i
w;  Group  NC,  naproxen  sodium-codeine  phosphate  group.
esponsive  to  a  glabellar  tap;  5:  sleeping  and  slowly  respon-
ive  to  tactile  stimuli;  and  6:  patient  unresponsive  to  painful
timuli)  and  were  recorded  at  the  same  time  points.
Hemodynamic  data  (systolic,  diastolic  and  mean  blood
ressure;  heart  rate)  and  peripheral  oxygen  saturation  were
ecorded  before  anesthesia  and  at  5,  10,  15,  30,  45  and
0  min  following  anesthetic  induction;  before  and  after  the
urgical  incision;  and  at  15  and  30  min  and  1,  2,  4,  6,  12  and
8  h  postoperatively.
Time  to  the  ﬁrst  demand  of  PCA,  total  meperidine  con-
umption,  and  postoperative  side  effects  such  as  sedation,
espiratory  depression,  constipation,  urinary  retention,  nau-
ea,  vomiting,  gastric  complaints  and  bleeding  in  the
urgical  area  were  recorded.
tatistical analysis
he  primary  outcome  parameter  of  this  study  was  visual
nalog  score  for  pain  at  the  ﬁrst  postoperative  hour.  Power
nalysis  of  the  study  was  based  on  a  study  by  Code  et  al.5
in-Epi  2.0  was  used  for  sample  size  calculation;  a  total  of
0  patients  with  30  patients  in  each  group  was  considered  to
e  an  appropriate  number  following  sample  size  calculation
or  a  95%  conﬁdence  interval  and  power  of  80%.The  compact  program  SPSS  17.0  (SPSS  Inc.,  Chicago,  IL,
SA)  was  used  for  statistical  analysis  of  the  data.  Categor-
cal  variables  were  expressed  as  numbers  and  percentages,
hereas  numerical  variables  were  expressed  as  mean  and
154  C.  Bali  et  al.
Table  1  Demographic  characteristics.
Group  N  Group  NC
Mean  ±  SD  (n  =  30)  Mean  ±  SD  (n  =  31)
Age  (years)  39.70  ±  13.21  42.03  ±  13.66
Weight (kg)  77.26  ±  12.84  78.35  ±  12.95
Height (cm)  171.13  ±  10.77  169.41  ±  10.03
Sex
(female/male)
15/15  16/15
ASA  (I-II)  17/13  15/16
Duration  of
surgery  (min)
33.43  ±  7.19  30.61  ±  6.08
Group N, naproxen sodium group; Group NC, naproxen sodium-
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Table  3  Visual  Analogue  pain  scores  on  movement.
Postoperative  Group  N  Group  NC  p
Times Median
(min--max)
Median
(min--max)
15  min  3  (0--5)  1  (0--3)  0.0001
30 min  3  (0--5)  2  (0--4)  0.0001
1 h  3  (0--5)  2  (0--4)  0.001
2 h  3  (1--4)  2  (0--4)  0.001
4 h  2  (1--5)  2  (0--3)  0.0001
6 h  3  (0--6)  1  (0--6)  0.0001
12 h 2  (0--4)  1  (0--3)  0.0001
18 h 2  (0--3) 1  (0--3)  >0.05
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pcodeine phosphate group; Data show the number of cases or
mean ± SD, mean ± standard deviation; ASA, American Society
of Anesthesiologists; min, minute.
tandard  deviation  (and  as  median  and  minimum--maximum
hen  necessary).  The  intergroup  comparison  of  numerical
ariables  was  performed  using  Student’s  t-test  when  the
ssumptions  were  fulﬁlled  and  the  Mann--Whitney  U  test
hen  the  assumptions  were  not  fulﬁlled.  For  parameters
ith  normal  distribution,  repeated  measures  analysis  and
he  paired  t-test  were  used  to  compare  dependent  varia-
les  whereas  the  Wilcoxon  test  or  the  Friedman  tests  were
therwise  used.  p-Values  less  than  0.05  were  considered
igniﬁcant  for  all  comparisons.
esults
ixty-two  patients  were  invited  to  participate.  During
creening,  one  patient  was  found  to  not  meet  the  inclusion
riteria,  so  sixty-one  patients  were  enrolled  in  the  study
Fig.  1).  The  groups  had  comparable  demographics,  includ-
ng  age,  body  weight,  height,  gender,  ASA  (American  Society
f  Anesthesiologists)  status  and  surgery  time  (Table  1).
There  were  no  signiﬁcant  differences  regarding  systolic
nd  diastolic  blood  pressure,  heart  rate  and  peripheral  oxy-
en  saturation  values  between  groups.  None  of  the  patients
xhibited  hypotension,  hypertension,  bradycardia  or  tachy-
ardia.
Median  VAS  scores  at  rest  were  signiﬁcantly  lower  in
roup  NC  compared  with  Group  N  at  all  measured  postopera-
ive  time  points  (15  min  through  18  h)  (Table  2).  Median  VAS
Table  2  Visual  Analogue  pain  scores  at  rest.
Postoperative  Group  N  Group  NC  p
Times Median
(min--max)
Median
(min--max)
15  min 3  (0--4)  1  (0--3)  0.0001
30 min 3  (0--4) 1  (0--3)  0.0001
1 h  3  (0--4)  2  (1--3)  0.0001
2 h  3  (0--4)  2  (0--3)  0.001
4 h  2  (1--4)  2  (0--3)  0.0001
6 h  2  (0--4)  1  (0--6)  0.0001
12 h  2  (0--3)  1  (0--3)  0.0001
18 h  2  (0--3)  1  (0--2)  0.0001
Group N, naproxen sodium group; Group NC, naproxen sodium-
codeine phosphate group; min--max, minimum--maximum.
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codeine phosphate group; min--max; minimum--maximum.
cores  on  movement  were  also  signiﬁcantly  lower  in  Group
C  compared  with  Group  N  except  for  the  score  at  18th h
ostoperatively  (Table  3).
The  median  time  to  patients’  ﬁrst  demand  of  PCA  was
9  min  in  Group  N  (10--240  min)  versus  135  min  (20--600  min)
n  Group  NC;  this  time  period  was  signiﬁcantly  shorter  in
roup  N  (p  <  0.001).  Consumption  of  intravenous  meperi-
ine  during  the  18  h  postoperatively  was  20  mg  in  Group  NC
10--50  mg)  versus  95  mg  (10--160  mg)  in  Group  N  (p  < 0.001).
Both  groups  had  similar  sedation  scores;  the  incidence
f  nausea  and  vomiting  did  not  signiﬁcantly  differ  between
roups  (p  >  0.05).  Bleeding  in  the  surgical  area,  gastric  com-
laints,  respiratory  depression,  constipation,  and  urinary
etention  were  not  observed  in  any  patients  in  either  group.
iscussion
n  this  study,  we  evaluated  the  efﬁcacy  of  preemptive
aproxen  sodium  and  naproxen  sodium-codeine  phosphate
n  patients  who  underwent  arthroscopic  meniscectomy.
e  have  demonstrated  that  preemptive  administration  of
aproxen  sodium-codeine  phosphate  signiﬁcantly  reduced
ostoperative  opioid  consumption  and  provided  more  effec-
ive  analgesia  compared  with  naproxen  sodium  alone.
NSAIDs  are  commonly  administered  for  arthroscopic  pro-
edures.  Faster  recovery,  more  rapid  return  of  movement
nd  quadriceps  function,  and  more  quick  return  to  work
ere  reported  when  NSAIDs  were  administered  for  arthro-
copic  surgeries.4,7 NSAIDs  suppress  the  acute  inﬂammatory
esponse  by  blocking  prostaglandin  synthesis  via  inhibition
f  the  enzyme  cyclooxygenase.8 NSAIDs  may  reduce  periph-
ral  nociception  by  reduction  of  the  inﬂammatory  response
o  surgical  trauma,8 and  they  may  also  modulate  the  central
esponse  to  painful  stimuli  by  inhibiting  prostaglandin  syn-
hesis  in  the  spinal  cord.9 Analgesic  efﬁcacy  of  NSAIDs  for
ostoperative  pain  has  been  investigated  in  many  studies,
nd  their  analgesic  efﬁcacy  is  considered  to  be  as  high  as
hat  of  opioids.10--13
Preemptive  analgesia  is  a  technique  that  enables  more
ffective  postoperative  pain  control.  It  produces  effective
nalgesia  through  a  reduction  in  peripheral  sensitization
efore  the  occurrence  of  the  noxius  stimuli  and  by  inter-
upting  the  transmission  of  noxious  peri-operative  inputs
o  the  spinal  cord.  Preventing  central  sensitization  reduces
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pain  and  analgesic  requirements  even  after  the  analgesic
effects  of  the  preemptive  agents  have  worn  off.14 Studies
have  shown  that  the  preemptive  administration  of  naproxen
sodium  provides  improved  postoperative  pain  control,  a
reduction  in  analgesic  usage,  or  both.5,15--17
Although  the  preemptive  administration  of  naproxen
sodium  has  been  studied,  there  are  no  other  studies  on
the  preemptive  efﬁcacy  of  the  naproxen-codeine  combina-
tion  since  this  preparation  is  a  new  agent  on  the  market.
Codeine,  a  prodrug  with  well-known  analgesic  efﬁcacy,  is
frequently  used  in  pain  management  in  combination  with
parasetamol.18 For  this  reason,  we  compared  naproxen
sodium  and  naproxen  sodium-codeine  phosphate  in  patients
undergoing  arthroscopic  meniscectomy.  In  our  study,  VAS
scores  were  signiﬁcantly  lower  in  Group  NC  compared  with
Group  N,  and  meperidine  consumption  was  signiﬁcantly
higher  in  Group  N.
The  analgesic  efﬁcacy  of  naproxen-codeine  may  be  due
to  the  prevention  of  sensitization  in  peripheral  and  cen-
tral  pathways  before  tissue  injury.  The  higher  efﬁcacy  of
naproxen-codeine  relative  to  naproxen  sodium  may  be  due
to  the  well-known  analgesic  efﬁcacy  of  codeine.  The  effec-
tive  dose  of  codeine  phosphate  is  30--60  mg,  with  higher
doses  opioid-related  side  effects  become  visible,  consti-
pation,  nausea,  and  respiratory  depression.18 A  previous
review  that  includes  data  from  14  clinical  trials  showed  that
the  combination  of  paracetamol  (600--1000  mg)  and  codeine
(30--60  mg)  provided  effective  analgesia  in  approximately
50%  of  patients  with  moderate  to  severe  postoperative  pain
and  that  this  combination  prolonged  duration  of  analgesia
compared  with  patients  receiving  paracetamol  alone.19 In
another  review,  which  included  35  clinical  trials  compar-
ing  codeine  (60--90  mg)  with  placebo  in  postoperative  pain
management,  single  agent  codeine  at  60  mg  provided  bet-
ter  analgesia  than  placebo.  However,  this  analgesia  was  not
sufﬁcient  when  a  comparison  was  made  between  codeine
alone  and  its  use  in  combination  with  paracetamol  and
NSAIDs.20 Similarly,  our  study  showed  more  effective  post-
operative  analgesia  and  lower  meperidine  consumption  with
the  naproxen  sodium-codeine  phosphate  combination.  In
previous  studies,  codeine  and  other  drugs  were  administered
as  different  pills  to  patients,  whereas  our  study  used  single
pills  that  included  both  naproxen  sodium  and  codeine.  This
may  be  an  advantage  for  patients,  as  it  contributes  to  usage
facility.  In  both  meta-analyses,  opioid-related  side  effects
such  as  drowsiness  and  somnolence  were  more  frequent  in
the  groups  receiving  codeine,  although  this  was  not  sta-
tistically  signiﬁcant.19,20 Forbes  et  al.  compared  naproxen
sodium,  codeine  sulfate,  naproxen  sodium  and  codeine  sul-
fate  for  postoperative  pain  after  oral  surgery.21 In  this
paper  codeine  dose  was  60  mg  in  groups  receiving  codeine
which  was  twice  the  dose  of  our  study.  Accordingly  they
reported  more  side  effects  with  codeine.  Although  our
study  was  not  powered  to  show  any  difference  between
the  groups  regarding  side  effects,  we  may  roughly  state
that  side  effects  such  as  sedation,  drowsiness,  nausea  and
vomiting  were  similar  between  the  groups.  This  may  be
interpreted  that  the  dosing  of  codeine  in  this  commercially
available  preparation  was  tolerable  by  the  patients  of  this
study.
Codeine  is  metabolized  in  the  liver  to  its  active
form  morphine  by  the  cytochrome  P-450  isoenzyme  2D6155
CYP2D6).22,23 CYP2D6  is  highly  polymorphic.  These  polymor-
hisms  create  different  phenotypes  for  codeine  metabolism,
rom  ultra-rapid  metabolism  to  poor  metabolism.  Ultra-
apid  metabolism  may  cause  high  levels  of  morphine  and
oxicity.22 Serious  adverse  events  and  deaths  were  reported
n  children  with  obstructive  sleep  apnea  (13  cases  in
n  estimated  >22  million  pediatric  tonsillectomies)  who
eceived  codeine  after  a  tonsillectomy  and/or  adenoidec-
omy.  Since  these  children  had  already  underlying  breathing
roblems  and  also  some  of  them  were  ultra-rapid  metab-
lizer,  the  U.S  Food  and  Drug  Administration  (FDA)  warns
bout  codein  use  in  all  children  after  tonsillectomy  and/or
denoidectomy.22,23 But  there  is  no  warning  about  codein
se  in  adults.
Although  the  beneﬁcial  effects  of  NSAIDs  have  been
emonstrated,  there  are  some  concerns  about  negative
ffects,  such  as  gastrointestinal  mucosal  damage,  renal
ubular  damage  and  platelet  dysfunction.24,25 In  our  study,
o  such  problems  occurred  related  to  NSAID  use.
onclusions
reemptive  oral  naproxen  sodium-codeine  phosphate  is  an
ffective  analgesic  option  in  patients  undergoing  arthro-
copic  meniscectomy  when  compared  with  oral  naproxen
odium,  and  it  carries  the  advantages  of  ease  of  administra-
ion  and  lack  of  serious  side  effects  at  this  dose.  We  suggest
hat  naproxen  sodium-codeine  phosphate  may  be  a valuable
ption  for  clinical  use  for  arthroscopic  procedures.
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